News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Merriman Curhan Ford & Co. Initiates Coverage on Helix Biopharma (CC:HBP)


8/3/2009 8:57:19 AM

SAN FRANCISCO--(BUSINESS WIRE)--Merriman Curhan Ford (NASDAQ: MERR) initiated equity research coverage today on Helix BioPharma (OTCQX: HXBPF | TSX: HBP) ($1.90), a Canadian biopharmaceutical company specializing in the field of cancer therapy, with a Buy rating.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES